JP2002531548A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002531548A5 JP2002531548A5 JP2000586691A JP2000586691A JP2002531548A5 JP 2002531548 A5 JP2002531548 A5 JP 2002531548A5 JP 2000586691 A JP2000586691 A JP 2000586691A JP 2000586691 A JP2000586691 A JP 2000586691A JP 2002531548 A5 JP2002531548 A5 JP 2002531548A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- methyl
- methylsulfinyl
- carbamoyl
- methoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 Cc1ccc(*)cc1S(C)=O Chemical compound Cc1ccc(*)cc1S(C)=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9826941.8 | 1998-12-09 | ||
| GBGB9826941.8A GB9826941D0 (en) | 1998-12-09 | 1998-12-09 | Compounds |
| PCT/GB1999/004118 WO2000034243A1 (en) | 1998-12-09 | 1999-12-06 | N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002531548A JP2002531548A (ja) | 2002-09-24 |
| JP2002531548A5 true JP2002531548A5 (https=) | 2007-01-25 |
Family
ID=10843818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000586691A Pending JP2002531548A (ja) | 1998-12-09 | 1999-12-06 | Ｎ−（２−フェニルー４−ピペリジニルブチル）−５，６，７，８−テトラヒドロー１−ナフタレンカルボキサミド、およびニューロキニン１（ｎｋ１）および／またはニューロキニン２（ｎｋ２）リセプター拮抗薬としてのそれらの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6403601B1 (https=) |
| EP (1) | EP1137637A1 (https=) |
| JP (1) | JP2002531548A (https=) |
| AU (1) | AU1667500A (https=) |
| GB (1) | GB9826941D0 (https=) |
| WO (1) | WO2000034243A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6898636B1 (en) * | 1999-02-04 | 2005-05-24 | Intralinks, Inc. | Methods and systems for interchanging documents between a sender computer, a server and a receiver computer |
| GB9911017D0 (en) * | 1999-05-13 | 1999-07-14 | Zeneca Ltd | Pharmaceutical compositions |
| US6903092B2 (en) | 2000-04-06 | 2005-06-07 | Peter Bernstein | Naphthamide neurokinin antagonists for use as medicaments |
| EP1276729B1 (en) * | 2000-04-06 | 2008-07-09 | AstraZeneca AB | New neurokinin antagonists for use as medicaments |
| DE60114597T2 (de) * | 2000-04-06 | 2006-07-20 | Astrazeneca Ab | Naphthamid-neurokinin antagonisten zur verwendung als medikamente |
| US6846814B2 (en) | 2000-04-06 | 2005-01-25 | Astra Zeneca Ab | Neurokinin antagonists for use as medicaments |
| GB0015246D0 (en) * | 2000-06-22 | 2000-08-16 | Astrazeneca Ab | Method for the treatment of urinary incontinence |
| SE0103668D0 (sv) * | 2001-11-02 | 2001-11-02 | Astrazeneca Ab | Method for the treatment of overactive blader |
| SE0103795D0 (sv) | 2001-11-02 | 2001-11-02 | Astrazeneca Ab | Compounds and method for the treatment of överactive bladder |
| TW200508221A (en) | 2003-06-13 | 2005-03-01 | Astrazeneca Ab | New azetidine compounds |
| US20040265238A1 (en) | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
| GB0418045D0 (en) | 2004-08-12 | 2004-09-15 | Glaxo Group Ltd | Compounds |
| SE0403005D0 (sv) * | 2004-12-09 | 2004-12-09 | Astrazeneca Ab | New use |
| AR057828A1 (es) | 2005-09-29 | 2007-12-19 | Astrazeneca Ab | Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica |
| AR056087A1 (es) * | 2005-09-29 | 2007-09-19 | Astrazeneca Ab | Derivados de azetidina como antagonistas de receptores de neuroquina nk |
| US8106208B2 (en) | 2006-05-18 | 2012-01-31 | Albireo Ab | Benzamide compounds that act as NK receptor antagonists |
| WO2008090114A1 (en) | 2007-01-24 | 2008-07-31 | Glaxo Group Limited | Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-) |
| CN120476107A (zh) | 2022-12-15 | 2025-08-12 | 先正达农作物保护股份公司 | 可用作杀有害生物剂的新型的二环-甲酰胺化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL99320A (en) * | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical compositions containing them |
| GB9310066D0 (en) * | 1993-05-17 | 1993-06-30 | Zeneca Ltd | Alkyl substituted heterocycles |
| GB9310713D0 (en) | 1993-05-24 | 1993-07-07 | Zeneca Ltd | Aryl substituted heterocycles |
| GB9617730D0 (en) * | 1996-08-23 | 1996-10-02 | Pfizer Ltd | Quarternary ammonium compounds |
| US5789422A (en) | 1996-10-28 | 1998-08-04 | Schering Corporation | Substituted arylalkylamines as neurokinin antagonists |
-
1998
- 1998-12-09 GB GBGB9826941.8A patent/GB9826941D0/en not_active Ceased
-
1999
- 1999-12-06 JP JP2000586691A patent/JP2002531548A/ja active Pending
- 1999-12-06 WO PCT/GB1999/004118 patent/WO2000034243A1/en not_active Ceased
- 1999-12-06 AU AU16675/00A patent/AU1667500A/en not_active Abandoned
- 1999-12-06 US US09/857,833 patent/US6403601B1/en not_active Expired - Fee Related
- 1999-12-06 EP EP99959534A patent/EP1137637A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002531548A5 (https=) | ||
| JP2002520316A5 (https=) | ||
| JP2004517087A5 (https=) | ||
| JP2005536475A5 (https=) | ||
| JP2007533741A5 (ja) | Ｂａｃｅ阻害剤として有用なピロリジン誘導体 | |
| JP2006518728A5 (https=) | ||
| JP2004525179A5 (https=) | ||
| JP2003525279A5 (https=) | ||
| JP2006517939A5 (https=) | ||
| JP2001526218A5 (https=) | ||
| JP2009528296A5 (https=) | ||
| JP2009523760A5 (https=) | ||
| JP2013521286A5 (https=) | ||
| JP2007182422A5 (https=) | ||
| JP2005527542A5 (https=) | ||
| WO2004013100A3 (fr) | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique | |
| JP2004524299A5 (https=) | ||
| JP2002526410A5 (https=) | ||
| JP2003505362A5 (https=) | ||
| JP2007515467A5 (https=) | ||
| JP2005521721A5 (https=) | ||
| CA2487238A1 (en) | Hydroxy tetrahydro-naphthalenylurea derivatives | |
| JP2006516626A5 (https=) | ||
| JP2004525178A5 (https=) | ||
| JP2006513222A5 (https=) |